These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18666377)

  • 1. Improving adherence to antipsychotic pharmacotherapy.
    Masand PS; Narasimhan M
    Curr Clin Pharmacol; 2006 Jan; 1(1):47-56. PubMed ID: 18666377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
    Sun SX; Liu GG; Christensen DB; Fu AZ
    Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.
    Lacro JP; Dunn LB; Dolder CR; Leckband SG; Jeste DV
    J Clin Psychiatry; 2002 Oct; 63(10):892-909. PubMed ID: 12416599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication adherence in patients with schizophrenia.
    Phan SV
    Int J Psychiatry Med; 2016; 51(2):211-9. PubMed ID: 27079779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
    Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
    J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to improve medication adherence in schizophrenia.
    Zygmunt A; Olfson M; Boyer CA; Mechanic D
    Am J Psychiatry; 2002 Oct; 159(10):1653-64. PubMed ID: 12359668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment adherence in schizophrenia and schizoaffective disorder.
    Goff DC; Hill M; Freudenreich O
    J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic medication adherence in schizophrenia.
    Byerly MJ; Nakonezny PA; Lescouflair E
    Psychiatr Clin North Am; 2007 Sep; 30(3):437-52. PubMed ID: 17720031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concordance in the treatment of schizophrenia].
    Suárez Richards M
    Vertex; 2004; 15(57):165-74. PubMed ID: 15505678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions to improve antipsychotic medication adherence: review of recent literature.
    Dolder CR; Lacro JP; Leckband S; Jeste DV
    J Clin Psychopharmacol; 2003 Aug; 23(4):389-99. PubMed ID: 12920416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics.
    Csernansky JG; Schuchart EK
    CNS Drugs; 2002; 16(7):473-84. PubMed ID: 12056922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.
    Svestka J; Bitter I
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():95-116. PubMed ID: 17262005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing side effects from antipsychotic treatment in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2011 Feb; 72(2):e07. PubMed ID: 21382302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients.
    Sapra M; Weiden PJ; Schooler NR; Sunakawa-McMillan A; Uzenoff S; Burkholder P
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):199-206. PubMed ID: 23428784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial compliance and patient consequences in schizophrenia: our patients can do better.
    Keith SJ; Kane JM
    J Clin Psychiatry; 2003 Nov; 64(11):1308-15. PubMed ID: 14658944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment adherence and long-term outcomes.
    Kane JM
    CNS Spectr; 2007 Oct; 12(10 Suppl 17):21-6. PubMed ID: 17934386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.
    Gilmer TP; Dolder CR; Lacro JP; Folsom DP; Lindamer L; Garcia P; Jeste DV
    Am J Psychiatry; 2004 Apr; 161(4):692-9. PubMed ID: 15056516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.